Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
PRNewsWire
·
2026-04-24
·
via The Tech Buzz - Press Releases
NEW YORK, April 24, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed I
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。